Agronomic portal Agronom.info
Categories
Language
Currency
My account
Nogotki

SAKHAROVSKAYA ORANGE

Assignment
Medicinal
Flower Color
Orange
Type of Inflorescence
Semimahrovoe
Country
Russia
No active offers.
Views
4
Reviews
0
Producer
INSTITUTE OF DEVELOPMENT BIOLOGY N.K. KOLTSO
Registration Year
1990
Manufacturer
INSTITUTE OF DEVELOPMENT BIOLOGY N.K. KOLTSO
Description SAKHAROVSKAYA ORANGE
Calendula «Sakharovskaya Orange» – a medicinal variety bred in Russia, known for its densely double-flowered inflorescences of bright orange color and high carotenoid content. These properties make the plant valuable for medical use: the calendula extract has antiseptic, bactericidal, and antiviral properties, effectively used in treating skin diseases, furuncles, contusions, infected wounds, and thermal burns. In folk medicine, a decoction from the flowers is used as a means to accelerate wound healing, reduce inflammation, and relieve pain.

The variety is distinguished by its resistance to diseases and pests, which makes it attractive for growing on private plots and in gardens. Calendula «Sakharovskaya Orange» grows easily in various climatic conditions due to its unpretentiousness: the plant prefers sunny places but can survive in moderate shade. To maintain plant health, regular feeding and removal of dried inflorescences are recommended.

Dried flowers of calendula are also used in cosmetology and decorative crafts: a decoction from the flowers is used to make soap, and dry flowers can decorate candles and other items. When storing dried flowers, keep them in a dry, dark place to preserve their aromatic properties. Contraindications include individual sensitivity to plant components.
Specifications SAKHAROVSKAYA ORANGE
Assignment
Medicinal
Flower Color
Orange
Type of Inflorescence
Semimahrovoe
Country
Russia
Registration Year
1990
Catalog
Varieties
Medicinal Plants
Manufacturer
INSTITUTE OF DEVELOPMENT BIOLOGY N.K. KOLTSO
Where to buy SAKHAROVSKAYA ORANGE
Loading...
Reviews SAKHAROVSKAYA ORANGE
0comments
Sort by:Popular first
No comments yet.